To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C17orf53TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
82 supporting clones for gene C17orf53 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC350778 brain .a 1 to 550 1 to 550       550/550
(100 %)
0 diff
(100 %id)
BI829278 brain, medulla .a 1 to 801 1 to 802   tiling clone,   802/803
(99 %)
3 diff
(99.7 %id)
TI_57176014   .a 1 to 801 72 to 873       802/874
(91 %)
9 diff
(99.0 %id)
NM_024032.3   .a 1 to 2725 1 to 2725 exact RefSeq, AAA   2725/2725
(100 %)
0 diff
(100 %id)
DC386245   .a 3 to 556 1 to 554       554/554
(100 %)
0 diff
(100 %id)
DC360267   .a 24 to 493 1 to 470       470/470
(100 %)
0 diff
(100 %id)
DC371508   .a 24 to 587 1 to 564       564/564
(100 %)
0 diff
(100 %id)
BM789193 stomach .a 34 to 726 1 to 693       693/693
(100 %)
1 diff
(99.9 %id)
DC386058   .a 34 to 335 1 to 302       302/302
(100 %)
0 diff
(100 %id)
DR159227 human embryonic stem cells differentiated toan early endodermal cell type .a 35 to 863 1 to 828       828/828
(100 %)
1 diff
(99.9 %id)
BG397608 B-cells, primary B-cells from tonsils (cell line) .a 38 to 781 1 to 745       745/745
(100 %)
2 diff
(99.8 %id)
BG341287 B-cells, primary B-cells from tonsils (cell line) .a 38 to 701 1 to 653       653/760
(85 %)
34 diff
(95.6 %id)
TI_57234270   .a 38 to 749 30 to 741       712/741
(96 %)
8 diff
(99.0 %id)
BI907713 leukocyte .a 39 to 749 1 to 711       711/711
(100 %)
3 diff
(99.6 %id)
AL834295 melanoma (MeWo cell line) .a 53 to 2725 1 to 2673 exact tiling clone, available from DKFZ, AAA   2673/2673
(100 %)
0 diff
(100 %id)
AA211819 germinal center B cell .a 75 to 292 1 to 221       221/221
(100 %)
6 diff
(97.3 %id)
BE254078 eye, retinoblastoma .a 80 to 610 1 to 530       530/530
(100 %)
1 diff
(99.9 %id)
DA617588   .a 90 to 674 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
CD644012 Embryonic Stem cells .a 102 to 864 8 to 769       762/769
(99 %)
8 diff
(99.0 %id)
BG470952 eye, retinoblastoma .a 116 to 888 1 to 794       794/889
(89 %)
66 diff
(92.6 %id)
CN256432 embryonic stem cells, cell lines H1, H7, andH9 .a 123 to 811 1 to 688       688/688
(100 %)
5 diff
(99.3 %id)
DA665503   .a 128 to 680 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA049961   .a 135 to 676 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
BE254723 eye, retinoblastoma .a 135 to 773 1 to 634       634/634
(100 %)
8 diff
(98.8 %id)
BE256936 eye, retinoblastoma .a 136 to 710 1 to 574       574/719
(79 %)
6 diff
(99.2 %id)
DA046866   .a 148 to 861 2 to 719   capped   718/726
(98 %)
5 diff
(99.4 %id)
BE896134 melanotic melanoma, skin .a 163 to 925 1 to 757       757/1100
(68 %)
24 diff
(97.9 %id)
CN256435 embryonic stem cells, DMSO-treated H9 cellline .a 173 to 410 1 to 238       238/238
(100 %)
0 diff
(100 %id)
CV025596 mixed .a 238 to 821 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
DA481154   .a 581 to 1121 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
BE891286 melanotic melanoma, skin .a 618 to 1432 1 to 818       818/860
(95 %)
38 diff
(95.6 %id)
BX328299   .a 656 to 1601 1 to 940       944/940
(100 %)
15 diff
(98.5 %id)
BE791055 lung, small cell carcinoma .a 702 to 1394 1 to 688       688/1007
(68 %)
15 diff
(98.6 %id)
CV406414 stomach .a 719 to 923 206 to 1     Submitted on the opposite strand 206/206
(100 %)
18 diff
(91.3 %id)
BG760304 melanotic melanoma, high MDR (cell line), skin .a 729 to 1339 1 to 611       611/611
(100 %)
1 diff
(99.9 %id)
BG762062 melanotic melanoma, high MDR (cell line), skin .a 729 to 1573 1 to 854       852/854
(99 %)
23 diff
(97.4 %id)
BG762079 melanotic melanoma, high MDR (cell line), skin .a 729 to 1598 1 to 868       868/917
(94 %)
28 diff
(97.0 %id)
AA156352 Pancreas .a 1484 to 1804 1 to 322       322/330
(97 %)
10 diff
(97.0 %id)
EH339787   .a 1605 to 1665 1 to 61       61/61
(100 %)
0 diff
(100 %id)
BX283513 brain, neuroblastoma, cell line .a 1734 to 2229 1 to 496       496/497
(99 %)
1 diff
(99.8 %id)
BQ070168 brain, neuroblastoma, cell line .a 1736 to 2479 1 to 756   AAA   756/1062
(71 %)
20 diff
(98.2 %id)
BX342442   .a 1798 to 2698 889 to 1       889/971
(91 %)
22 diff
(97.8 %id)
BG324056 Kidney, renal cell adenocarcinoma .a 1842 to 2513 1 to 669       669/669
(100 %)
5 diff
(99.3 %id)
BG424609 Kidney, renal cell adenocarcinoma .a 1842 to 2527 1 to 681       683/681
(100 %)
9 diff
(98.7 %id)
BX331104   .a 1889 to 2721 835 to 1       835/838
(99 %)
31 diff
(96.4 %id)
CN256433 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1915 to 2545 1 to 631       631/631
(100 %)
7 diff
(98.9 %id)
BU537378 mixed (pool of 40 RNAs) .a 1929 to 2592 1 to 677       677/968
(69 %)
21 diff
(97.9 %id)
BG194937   .a 2118 to 2725 1 to 608       608/686
(88 %)
6 diff
(99.2 %id)
DB353327   .a 2153 to 2725 562 to 1       562/572
(98 %)
18 diff
(96.9 %id)
CA423137 cell lines, Chondrosarcoma .a 2170 to 2725 574 to 19   AAA   556/556
(100 %)
3 diff
(99.5 %id)
AW190669 adenocarcinoma, Pancreas .a 2291 to 2725 450 to 14   AAA   437/437
(100 %)
7 diff
(98.4 %id)
AI003902   .a 2297 to 2725 451 to 22   AAA   430/430
(100 %)
0 diff
(100 %id)
AA156317 Pancreas .a 2363 to 2725 365 to 2       364/377
(96 %)
0 diff
(100 %id)
AA749347 germinal center B cell .a 2380 to 2725 378 to 33   AAA   346/346
(100 %)
0 diff
(100 %id)
AA933995 pooled .a 2410 to 2648 239 to 1       239/239
(100 %)
0 diff
(100 %id)
AA513654 breast .a 2411 to 2725 319 to 5       315/319
(98 %)
0 diff
(100 %id)
AA600844 breast .a 2411 to 2725 319 to 5       315/319
(98 %)
0 diff
(100 %id)
BF438465 brain, glioblastoma (pooled) .a 2430 to 2725 296 to 1       296/296
(100 %)
1 diff
(99.7 %id)
AA814766 germinal center B cell .a 2432 to 2725 326 to 33   AAA   294/294
(100 %)
0 diff
(100 %id)
NM_001171251.1   .b 1 to 2722 1 to 2722 exact RefSeq, AAA   2722/2722
(100 %)
0 diff
(100 %id)
AK291924   .b 3 to 2531 1 to 2529 exact tiling clone,   2529/2529
(100 %)
0 diff
(100 %id)
BM472876 duodenal adenocarcinoma, cell line, small intestine .b 1415 to 2116 1 to 711       711/1079
(65 %)
21 diff
(98.1 %id)
BC000121 Eye, retinoblastoma .c 1 to 2272 1 to 2272 T166P tiling clone, available from MGC, AAA   2272/2272
(100 %)
3 diff
(99.9 %id)
TI_1948094975   .c 124 to 1013 128 to 1032       905/1451
(62 %)
55 diff
(96.3 %id)
TI_1948095136   .c 124 to 1050 130 to 1048   fully sequenced,   919/1048
(87 %)
30 diff
(97.2 %id)
TI_1948095292   .c 124 to 1071 130 to 1077       948/1385
(68 %)
57 diff
(95.9 %id)
BX280827 embryonal carcinoma, cell line, testis .c 965 to 1450 1 to 486       486/486
(100 %)
0 diff
(100 %id)
TI_1948095137   .c 1020 to 1666 802 to 147   fully sequenced,   656/802
(81 %)
16 diff
(98.1 %id)
TI_1948094836   .c 1181 to 1666 634 to 146       489/1402
(34 %)
13 diff
(99.1 %id)
TI_1948094976   .c 1185 to 1666 629 to 146       484/1350
(35 %)
18 diff
(98.7 %id)
TI_1948095293   .c 1232 to 1666 581 to 147       435/1405
(30 %)
2 diff
(99.9 %id)
AF039239 Hip .d 1 to 1388 1 to 1384 A32X S46X D181X P247R Q248N ... tiling clone,   1384/1386
(99 %)
6 diff
(99.6 %id)
BQ420279 embryonal carcinoma, cell line, testis .e 1 to 864 1 to 868 P246A E247R S277E E278* tiling clone,   868/871
(99 %)
13 diff
(98.6 %id)
BE747252 adenocarcinoma cell line, ovary .f 1 to 778 1 to 768 C15G I66M S68L P69L V70W ... tiling clone,   768/984
(78 %)
16 diff
(98.4 %id)
CN256431 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 1 to 409 1 to 410   tiling clone,   410/410
(100 %)
6 diff
(98.6 %id)
CN256434 embryonic stem cells, DMSO-treated H9 cellline .g 295 to 1054 8 to 768 exact tiling clone,   761/770
(98 %)
10 diff
(98.8 %id)
BX343005   .h 1 to 1094 1081 to 1 S2X I3M S5P P6F V7X ... tiling clone,   1081/1096
(98 %)
27 diff
(97.6 %id)
BX343006   .i 1 to 1003 1 to 993 exact tiling clone,   993/1042
(95 %)
10 diff
(99.1 %id)
AK021656 whole embryo, mainly head Gene C17orf53, variant not shown       available from FLJ, Suspected internal deletion, suspected internal deletion, this clone was ignored    
AW972603   Gene C17orf53, variant not shown         Submitted on the opposite strand    
BE772828 prostate_tumor Gene C17orf53, variant not shown              
AU145069 whole embryo, mainly head Gene C17orf53, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
AU118529 whole embryo, mainly head Gene C17orf53, variant not shown       capped Suspected internal deletion, suspected internal deletion, this clone was ignored    
AA131006 colon, tumor Gene C17orf53, variant not shown       fully sequenced,      
AA131060 colon, tumor Gene C17orf53, variant not shown       fully sequenced,      
AA526897 breast Gene C17orf53, variant not shown              
AI369403 anaplastic oligodendroglioma, brain Gene C17orf53, variant not shown         Suspected internal deletion, this clone was ignored    
AW448922   Gene C17orf53, variant not shown       AAA Suspected internal deletion, this clone was ignored    
DB098201 testis Gene C17orf53, variant not shown       capped      
DB341870 testis Gene C17orf53, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC